Literature DB >> 2271955

Development of hippocampal long-term potentiation is reduced by recently introduced calpain inhibitors.

S del Cerro1, J Larson, M W Oliver, G Lynch.   

Abstract

The effects of two recently synthesized inhibitors of calpains, calpain inhibitor I (CiI) and calpain inhibitor II (CiII) were tested on the development of long-term potentiation (LTP) in region CA1 of rat hippocampus. Slices maintained in 100 microM of CiI or CiII showed an initial degree of potentiation after theta burst stimulation that, in contrast to controls, slowly decayed across time. The effects of CiI and CiII appeared to be independent of possible actions on the physiological mechanisms that take place during the induction stage of LTP. Since these inhibitors are more potent and specific than leupeptin in blocking calpain activity, their effects on LTP can be more convincingly ascribed to a selective blockade of the calcium-sensitive protease. Accordingly, the results favor the idea that a proteolytic event of the kind found after N-methyl-D-aspartate receptor activation is an intermediary step in the development of LTP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271955     DOI: 10.1016/0006-8993(90)90660-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

1.  Marking synaptic activity in dendritic spines with a calpain substrate exhibiting fluorescence resonance energy transfer.

Authors:  P W Vanderklish; L A Krushel; B H Holst; J A Gally; K L Crossin; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Calpain-PKC inter-relations in mouse hippocampus: a biochemical approach.

Authors:  K Touyarot; S Poussard; C Verret; B Aragon; P Cottin; X Nogues; J Micheau
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

3.  Glycine-induced long-term potentiation is associated with structural and functional modifications of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  W Musleh; X Bi; G Tocco; S Yaghoubi; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.

Authors:  Ivan L Salazar; Margarida V Caldeira; Michele Curcio; Carlos B Duarte
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

Review 5.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

6.  Integrin-driven actin polymerization consolidates long-term potentiation.

Authors:  Enikö A Kramár; Bin Lin; Christopher S Rex; Christine M Gall; Gary Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

7.  45Ca exchange in rat cortex slices in conditions of long-term potentiation.

Authors:  N E Sokolova; U M Malikov; V L Kuznetsov; N A Emel'yanov
Journal:  Neurosci Behav Physiol       Date:  1998 Sep-Oct

8.  Postsynaptic inhibitors of calcium/calmodulin-dependent protein kinase type II block induction but not maintenance of pairing-induced long-term potentiation.

Authors:  N Otmakhov; L C Griffith; J E Lisman
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

9.  Different patterns of electrical activity lead to long-term potentiation by activating different intracellular pathways.

Authors:  Guoqi Zhu; Yan Liu; Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

10.  Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury.

Authors:  Mandana Amini; Chun-lei Ma; Rasoul Farazifard; Guoqi Zhu; Yi Zhang; Jacqueline Vanderluit; Joanna Susie Zoltewicz; Fadi Hage; Joseph M Savitt; Diane C Lagace; Ruth S Slack; Jean-Claude Beique; Michel Baudry; Peter A Greer; Richard Bergeron; David S Park
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.